AI-generated summary
The authors surveyed 241 dermatologists practicing in Spain through online questionnaires about how they treat male and female androgenetic alopecia. Topical minoxidil was the most frequently prescribed treatment across groups, with oral finasteride and nutricosmetics also common, and the authors note that many treatments are used off-label. The study describes prescribing habits rather than treatment outcomes.
- Participants
- 241
- Who or what was studied
- Dermatologists working in Spain who completed online questionnaires about androgenetic alopecia prescribing in 2017
- Limits stated in the abstract
- The authors state they did not analyze novel treatments such as oral minoxidil and dutasteride mesotherapy.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Androgenetic alopecia. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.